Bioorthogonal Iontronic Chemistry: Spatiotemporal Drug Release with Electronic Precision

Develop a programmable drug delivery system using Biontronic Chemistry for precise spatiotemporal release, enhancing treatment efficacy while minimizing side effects in various therapies.

Subsidie
€ 1.496.795
2024

Projectdetails

Introduction

I envision a new drug delivery system capable of spatiotemporal release with electronic precision. This technology is based on Biontronic Chemistry (BC), which combines Bioorthogonal Release (BR) and Iontronic transport to overcome the drawbacks of each individual technology and combine their unique advantages.

Technology Overview

An electronic ion pump (IP) will enable programmable electrophoretic transport of chemical triggers without liquid flow or moving mechanical parts. This will initiate the ultrafast and selective bioorthogonal release (BR) of drugs at the target site to generate previously unobtainable dynamic concentration-time profiles.

Hence, BC translates electrical stimuli, of arbitrary frequencies and amplitudes, into tailor-made biochemical concentration/time profiles.

Expansion of the Concept

By incorporating surface release functionalities and orthogonal bioorthogonal chemistries, I will further expand the concept and demonstrate choreographed cascade releases. This will afford individually programmable release of multiple compounds with distinct concentration/time profiles.

Methodology

We will map out this large parameter space using a combination of:

  1. Rational chemical design
  2. Computationally aided device physics and engineering
  3. Fluorescent model systems
  4. Evaluation in cell models

Implications for Science and Therapy

T2S will lay the foundation for new directions in science and offer unprecedented opportunities for various therapies wherein choreographed, spatiotemporal control of multiple drug releases is key (e.g., cancer, nerve regeneration, and aging).

Hypothesis and Goals

My hypothesis is that if we combine local drug delivery and chronotherapy, we can dramatically increase treatment efficacy and reduce (if not completely eliminate) side effects.

My overarching goal is to create a Switch that elevates medicine to the 5th dimension (5D), thus paving the way towards a paradigm shift in drug delivery and our understanding/ability to manipulate biological spacetime by delivering the right dose (1D) at the right place (3D) at the right time (1D).

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.496.795
Totale projectbegroting€ 1.496.795

Tijdlijn

Startdatum1-9-2024
Einddatum31-8-2029
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • TECHNISCHE UNIVERSITAET WIENpenvoerder

Land(en)

Austria

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

On-Demand Bioresorbable OptoElectronic System for In-Vivo and In-Situ Monitoring of Chemotherapeutic Drugs

Develop a bioresorbable chemical sensing system for real-time monitoring of doxorubicin in-vivo, enhancing personalized cancer treatment while eliminating the need for device retrieval surgery.

€ 2.606.250
EIC Pathfinder

Bioorthogonal Implantable Iontronic Switch to Temporally Control the Local Release of Chemotherapeutics

The project aims to develop an implantable bioSWITCH for on-demand drug delivery to tumors, enhancing treatment efficacy and survival rates in pancreatic cancer.

€ 4.420.511
EIC Pathfinder

In-situ & operando organiC electrochemical transistors monitored by non-destructive spectroscopies for Organic cmos-like NeuromorphIc Circuits

ICONIC aims to advance implantable AI organic electronic devices for chronic disease management by investigating PMIECs, leading to smart drug-delivery systems with enhanced accuracy and safety.

€ 2.664.940
ERC ADG

Remote controlling biological systems by sonopharmacology and sonogenetics

This project aims to develop biocompatible ultrasound technology to control drug, protein, and gene activity, enhancing therapies for cancer, diabetes, and tissue engineering while minimizing side effects.

€ 2.500.000